Recurrent Distal Bile Duct Adenocarcinoma
1 clinical trials · Condition
◉ Watch Recurrent Distal Bile Duct Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer (NCT04941287) | National Cancer Institute (NCI) | 2021-12-15 |
Track Recurrent Distal Bile Duct Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.